Related references
Note: Only part of the references are listed.Role of autologous and allogeneic stem cell transplantation in myeloma
W. I. Bensinger
LEUKEMIA (2009)
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
S. Giralt et al.
LEUKEMIA (2009)
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Shaji K. Kumar et al.
MAYO CLINIC PROCEEDINGS (2009)
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
Laura Rosinol et al.
BLOOD (2008)
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
G. Schilling et al.
LEUKEMIA (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Recent major improvement in long-term survival of younger patients with multiple myeloma
Hermann Brenner et al.
BLOOD (2008)
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
Gosta Gahrton et al.
HAEMATOLOGICA (2007)
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma
John Kuruvilla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
A comparison of allografting with autografting for newly diagnosed myeloma
Benedetto Bruno et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation
N. Kroeger
LEUKEMIA (2007)
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
F Garban et al.
BLOOD (2006)
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma
S Gerull et al.
BONE MARROW TRANSPLANTATION (2005)
Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma
M Arora et al.
BONE MARROW TRANSPLANTATION (2005)
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma:: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
C Crawley et al.
BLOOD (2005)
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
N Kröger et al.
BLOOD (2004)
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma
N Kröger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect
E Alyea et al.
BONE MARROW TRANSPLANTATION (2003)
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma
P Corradini et al.
BLOOD (2003)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma
S Giralt et al.
BONE MARROW TRANSPLANTATION (2002)
Allogeneic transplantation for multiple myeloma:: further evidence for a GVHD-associated graft-versus-myeloma effect
R Le Blanc et al.
BONE MARROW TRANSPLANTATION (2001)
Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma:: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres
G Gahrton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
